BridgeBio Pharma BBIO Cost Of License And Services Revenue — Cost Of Revenue

Other product segments

Similar metrics at other companies

BRKRLicense — Cost Of Revenue

$2.48M-2.0%

AXSMLicense — Cost Of Revenue

$1M—

NTRALicensing and other revenues — Cost of revenues

$608K+34.5%

MRNALicense agreement — Cost of Sales

$400M—

BIIBRoyalty and other revenue — Total Revenue

$9.7M-11.8%

CYTKLicense And Service — Revenue

$1.92M+502%

Questions, answered.

What is BridgeBio Pharma's cost of license and services revenue — cost of revenue?

BridgeBio Pharma (BBIO) reported cost of license and services revenue — cost of revenue of $605K in Q1 2025.

What does cost of license and services revenue — cost of revenue mean?

The direct expenses associated with earning revenue from licensing intellectual property and providing professional services.

How do you interpret cost of license and services revenue — cost of revenue?

An increase in these costs relative to revenue may indicate higher royalty obligations or increased service delivery expenses, potentially compressing margins. A decrease suggests improved cost management or a shift toward higher-margin licensing arrangements.

How does cost of license and services revenue — cost of revenue compare across companies?

Peers in the biotechnology and pharmaceutical sectors report similar costs under cost of revenue, often categorized as royalty expenses or service costs, which are typically benchmarked against total licensing revenue to determine segment gross margin.